Bone Biologics Corp SEC filings BBLG

Bone Biologics Corp has 485 filings in SEC EDGAR's recent list, going back to Feb 1, 2008. Its latest annual report, Form ARS, was filed on Jul 2, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 26, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Sep 29, 2026 (shareholder vote results). The company's fiscal year ends on December 31.

Bone Biologics Corp SEC filings
Form Description Filed Period
10-Q Quarterly report Oct 26, 2026 Sep 30, 2026
25-NSE Delisting notice Oct 13, 2026 —
4 Insider transaction Sep 30, 2026 Sep 28, 2026
4 Insider transaction Sep 30, 2026 Sep 28, 2026
4 Insider transaction Sep 30, 2026 Sep 28, 2026
4 Insider transaction Sep 30, 2026 Sep 28, 2026
8-K Current report
Shareholder vote results
Sep 29, 2026 Sep 28, 2026
8-K Current report
Listing notice
Sep 16, 2026 Sep 10, 2026
DEF 14A Proxy statement Aug 28, 2026 Aug 28, 2026
PRE 14A Preliminary proxy statement Aug 18, 2026 Aug 18, 2026
10-Q Quarterly report Aug 14, 2026 Jun 30, 2026
EFFECT Filing Jul 24, 2026 —
424B3 Prospectus Jul 24, 2026 —
8-K Current report
Regulation FD disclosure
Jul 23, 2026 Jul 23, 2026
DEFA14A Additional proxy material Jul 20, 2026 —
S-3 Shelf registration Jul 17, 2026 —
8-K Current report
Other events
Jul 16, 2026 Jul 15, 2026
8-K Current report
Material agreement, Unregistered share sale, Other events
Jul 9, 2026 Jul 7, 2026
ARS Annual report to shareholders Jul 2, 2026 Dec 31, 2025
DEFA14A Additional proxy material Jul 2, 2026 —
DEF 14A Proxy statement Jul 2, 2026 Jul 2, 2026
10-Q Quarterly report May 14, 2026 Mar 31, 2026
8-K Current report
Other events
Mar 13, 2026 Mar 13, 2026
424B5 Prospectus supplement Mar 13, 2026 —
10-K Annual report Mar 2, 2026 Dec 31, 2025
4 Insider transaction Jan 21, 2026 Jan 8, 2026
4 Insider transaction Jan 21, 2026 Jan 8, 2026
8-K Current report
Regulation FD disclosure
Jan 8, 2026 Jan 8, 2026
10-Q Quarterly report Nov 14, 2025 Sep 30, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 7, 2025 —
S-8 Employee stock plan registration Sep 26, 2025 —
8-K Current report
Regulation FD disclosure
Sep 4, 2025 Sep 4, 2025
EFFECT Filing Sep 2, 2025 —
CORRESP Letter to the SEC Aug 29, 2025 —
S-3/A Filing Aug 29, 2025 —
10-Q Quarterly report Aug 14, 2025 Jun 30, 2025
SCHEDULE 13G Ownership over 5% (passive) Jul 3, 2025 —
UPLOAD Letter from the SEC Jul 1, 2025 —
8-K Current report
Material agreement, Other events
Jun 30, 2025 Jun 27, 2025
424B4 Prospectus Jun 30, 2025 —
EFFECT Filing Jun 27, 2025 —
8-K Current report
Other events
Jun 26, 2025 Jun 25, 2025
CORRESP Letter to the SEC Jun 24, 2025 —
S-3 Shelf registration Jun 24, 2025 —
S-1 Registration statement Jun 24, 2025 —
4 Insider transaction Jun 6, 2025 Jun 4, 2025
4 Insider transaction Jun 6, 2025 Jun 4, 2025
4 Insider transaction Jun 6, 2025 Jun 4, 2025
4 Insider transaction Jun 6, 2025 Jun 4, 2025
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change, Other events
Jun 6, 2025 Jun 5, 2025
8-K Current report
Officer or director change, Shareholder vote results
May 30, 2025 May 30, 2025
10-Q Quarterly report May 12, 2025 Mar 31, 2025
ARS Annual report to shareholders Apr 23, 2025 Dec 31, 2024
DEF 14A Proxy statement Apr 23, 2025 Dec 31, 2024
PRE 14A Preliminary proxy statement Apr 11, 2025 Dec 31, 2024
8-K Current report
Listing notice
Apr 11, 2025 Apr 7, 2025
8-K Current report Apr 1, 2025 Mar 26, 2025
UPLOAD Letter from the SEC Mar 24, 2025 —
DRS Filing Mar 17, 2025 —
DRSLTR Filing Mar 17, 2025 —
10-K Annual report Feb 26, 2025 Dec 31, 2024
4 Insider transaction Jan 21, 2025 Jan 15, 2025
4 Insider transaction Jan 21, 2025 Jan 15, 2025
8-K Current report
Other events
Dec 13, 2024 Dec 13, 2024
424B5 Prospectus supplement Dec 13, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
10-Q Quarterly report Nov 14, 2024 Sep 30, 2024
SC 13G/A Amended ownership over 5% (passive) Nov 13, 2024 —
8-K Current report
Officer or director change
Oct 21, 2024 Oct 16, 2024
4 Insider transaction Oct 18, 2024 Oct 16, 2024
3 Initial insider ownership Oct 18, 2024 Oct 16, 2024
8-K Current report
Officer or director change
Oct 4, 2024 Oct 1, 2024
8-K Current report
Material agreement
Sep 27, 2024 Sep 27, 2024
424B5 Prospectus supplement Sep 27, 2024 —
4 Insider transaction Sep 19, 2024 Sep 17, 2024
4 Insider transaction Sep 19, 2024 Sep 17, 2024
4 Insider transaction Sep 19, 2024 Sep 17, 2024
8-K Current report
Shareholder vote results
Sep 19, 2024 Sep 17, 2024
EFFECT Filing Aug 26, 2024 —
CORRESP Letter to the SEC Aug 22, 2024 —
UPLOAD Letter from the SEC Aug 21, 2024 —
S-3 Shelf registration Aug 12, 2024 —
10-Q Quarterly report Aug 9, 2024 Jun 30, 2024
ARS Annual report to shareholders Aug 8, 2024 Dec 31, 2023
DEFA14A Additional proxy material Aug 8, 2024 —
DEF 14A Proxy statement Aug 8, 2024 Aug 8, 2024
8-K Current report
Material agreement, Unregistered share sale, Other events
Aug 2, 2024 Aug 1, 2024
SC 13G/A Amended ownership over 5% (passive) Jun 28, 2024 —
8-K Current report
Regulation FD disclosure
Jun 20, 2024 Jun 20, 2024
10-Q Quarterly report May 14, 2024 Mar 31, 2024
8-K Current report
Officer or director change
Mar 15, 2024 Mar 12, 2024
SC 13G Ownership over 5% (passive) Mar 14, 2024 —
8-K Current report
Material agreement, Other events
Mar 6, 2024 Mar 4, 2024
EFFECT Filing Mar 4, 2024 —
424B4 Prospectus Mar 4, 2024 —
CORRESP Letter to the SEC Mar 1, 2024 —
8-K Current report
Other events
Mar 1, 2024 Mar 1, 2024
CORRESP Letter to the SEC Feb 29, 2024 —
CORRESP Letter to the SEC Feb 28, 2024 —
CORRESP Letter to the SEC Feb 27, 2024 —
S-1/A Amended registration statement Feb 26, 2024 —
S-1/A Amended registration statement Feb 23, 2024 —
10-K Annual report Feb 21, 2024 Dec 31, 2023
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 13, 2024 —
UPLOAD Letter from the SEC Feb 5, 2024 —
S-1 Registration statement Jan 30, 2024 —
EFFECT Filing Jan 24, 2024 —
CORRESP Letter to the SEC Jan 22, 2024 —
4 Insider transaction Jan 19, 2024 Jan 17, 2024
4 Insider transaction Jan 19, 2024 Jan 17, 2024
S-3/A Filing Jan 17, 2024 —
8-K Current report
Other events
Jan 12, 2024 Jan 10, 2024
UPLOAD Letter from the SEC Jan 11, 2024 —
8-K Current report
Officer or director change
Jan 11, 2024 Jan 8, 2024
4 Insider transaction Jan 10, 2024 Jan 8, 2024
3 Initial insider ownership Jan 10, 2024 Jan 8, 2024
8-K Current report
Other events
Jan 10, 2024 Jan 9, 2024
S-3 Shelf registration Jan 5, 2024 —
8-K Current report
Officer or director change
Jan 2, 2024 Dec 27, 2023
SC 13G/A Amended ownership over 5% (passive) Jan 2, 2024 —
SC 13G/A Amended ownership over 5% (passive) Dec 20, 2023 —
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change, Other events
Dec 18, 2023 Dec 14, 2023
8-K Current report
Shareholder vote results, Other events
Dec 13, 2023 Dec 12, 2023
D Filing Nov 29, 2023 —
SC 13G Ownership over 5% (passive) Nov 27, 2023 —
8-K Current report
Material agreement, Unregistered share sale, Other events
Nov 20, 2023 Nov 16, 2023
424B5 Prospectus supplement Nov 20, 2023 —
DEF 14A Proxy statement Nov 20, 2023 Nov 20, 2023
10-K/A Amended annual report Nov 20, 2023 Dec 31, 2022
10-Q Quarterly report Nov 14, 2023 Sep 30, 2023
PRE 14A Preliminary proxy statement Nov 9, 2023 Nov 9, 2023
8-K Current report
Bylaw or fiscal year change
Oct 24, 2023 Oct 20, 2023
8-K Current report
Listing notice
Sep 29, 2023 Sep 27, 2023
4 Insider transaction Sep 20, 2023 Sep 18, 2023
4 Insider transaction Sep 20, 2023 Sep 18, 2023
4 Insider transaction Sep 20, 2023 Sep 18, 2023
S-8 Employee stock plan registration Sep 15, 2023 —
4 Insider transaction Sep 14, 2023 Sep 13, 2023
8-K Current report
Shareholder vote results
Sep 12, 2023 Sep 12, 2023
4 Insider transaction Sep 12, 2023 Sep 11, 2023
4 Insider transaction Sep 7, 2023 Sep 6, 2023
4 Insider transaction Sep 5, 2023 Aug 31, 2023
10-Q Quarterly report Aug 14, 2023 Jun 30, 2023
ARS Annual report to shareholders Aug 3, 2023 Dec 31, 2022
DEFA14A Additional proxy material Aug 3, 2023 —
DEF 14A Proxy statement Aug 3, 2023 Aug 3, 2023
8-K Current report
Other events
Jul 5, 2023 Jun 28, 2023
SC 13G Ownership over 5% (passive) Jun 26, 2023 —
8-K Current report
Material agreement, Other events
Jun 16, 2023 Jun 14, 2023
424B4 Prospectus Jun 16, 2023 —
EFFECT Filing Jun 14, 2023 —
CORRESP Letter to the SEC Jun 13, 2023 —
CORRESP Letter to the SEC Jun 13, 2023 —
S-1/A Amended registration statement Jun 13, 2023 —
S-1/A Amended registration statement Jun 6, 2023 —
8-K Current report
Bylaw or fiscal year change
Jun 6, 2023 Jun 5, 2023
8-K Current report
Listing notice
May 19, 2023 May 18, 2023
10-Q Quarterly report May 15, 2023 Mar 31, 2023
DEF 14C Information statement May 11, 2023 May 11, 2023
UPLOAD Letter from the SEC May 8, 2023 —
S-1 Registration statement May 1, 2023 —
PRE 14C Filing May 1, 2023 May 1, 2023
10-K Annual report Mar 30, 2023 Dec 31, 2022
SC 13D/A Amended ownership over 5% (active) Mar 29, 2023 —
4 Insider transaction Mar 29, 2023 Mar 27, 2023
4 Insider transaction Mar 8, 2023 Aug 23, 2022
4 Insider transaction Mar 8, 2023 Aug 23, 2022
4 Insider transaction Mar 8, 2023 Jan 25, 2023
4 Insider transaction Mar 8, 2023 Aug 23, 2022
4 Insider transaction Mar 8, 2023 Jan 25, 2023
SC 13G Ownership over 5% (passive) Feb 14, 2023 —
SC 13G/A Amended ownership over 5% (passive) Feb 13, 2023 —
SC 13G Ownership over 5% (passive) Jan 4, 2023 —
8-K Current report
Officer or director change
Dec 21, 2022 Dec 18, 2022
8-K Current report
Listing notice
Nov 21, 2022 Nov 17, 2022
10-Q Quarterly report Nov 14, 2022 Sep 30, 2022
8-K Current report
Other events
Oct 25, 2022 Oct 25, 2022
8-K Current report
Other events
Oct 13, 2022 Oct 12, 2022
SC 13G Ownership over 5% (passive) Oct 12, 2022 —
8-K Current report
Material agreement, Other events
Oct 11, 2022 Oct 7, 2022
424B4 Prospectus Oct 11, 2022 —
S-1MEF Filing Oct 7, 2022 —
S-1MEF Filing Oct 7, 2022 —
EFFECT Filing Oct 6, 2022 —
S-1/A Amended registration statement Oct 5, 2022 —
CORRESP Letter to the SEC Oct 4, 2022 —
CORRESP Letter to the SEC Oct 4, 2022 —
S-1/A Amended registration statement Oct 4, 2022 —
UPLOAD Letter from the SEC Sep 30, 2022 —
S-1 Registration statement Sep 23, 2022 —
8-K Current report
Shareholder vote results
Aug 24, 2022 Aug 23, 2022
10-Q Quarterly report Aug 11, 2022 Jun 30, 2022
EFFECT Filing Jul 11, 2022 —
CORRESP Letter to the SEC Jul 7, 2022 —
UPLOAD Letter from the SEC Jul 6, 2022 —
DEF 14A Proxy statement Jul 6, 2022 Jul 6, 2022
S-3 Shelf registration Jun 28, 2022 —
8-K Current report
Material agreement
Jun 9, 2022 Jun 8, 2022

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Orthopedic, Prosthetic & Surgical Appliances & Supplies (SIC 3842)
Listed as
BBLG (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Burlington, MA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1419554
Former names
Bone Biologics, Corp. (until Nov 2, 2015); AFH ACQUISITION X, INC. (until Sep 15, 2014)

Other Orthopedic, Prosthetic & Surgical Appliances & Supplies companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.